These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

739 related articles for article (PubMed ID: 11992863)

  • 1. Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation.
    Shields CL; Honavar SG; Meadows AT; Shields JA; Demirci H; Singh A; Friedman DL; Naduvilath TJ
    Am J Ophthalmol; 2002 May; 133(5):657-64. PubMed ID: 11992863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemoreduction for unilateral retinoblastoma.
    Shields CL; Honavar SG; Meadows AT; Shields JA; Demirci H; Naduvilath TJ
    Arch Ophthalmol; 2002 Dec; 120(12):1653-8. PubMed ID: 12470138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation.
    Gündüz K; Günalp I; Yalçindağ N; Unal E; Taçyildiz N; Erden E; Geyik PO
    Ophthalmology; 2004 Oct; 111(10):1917-24. PubMed ID: 15465557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macular retinoblastoma managed with chemoreduction: analysis of tumor control with or without adjuvant thermotherapy in 68 tumors.
    Shields CL; Mashayekhi A; Cater J; Shelil A; Ness S; Meadows AT; Shields JA
    Arch Ophthalmol; 2005 Jun; 123(6):765-73. PubMed ID: 15955977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors predictive of recurrence of retinal tumors, vitreous seeds, and subretinal seeds following chemoreduction for retinoblastoma.
    Shields CL; Honavar SG; Shields JA; Demirci H; Meadows AT; Naduvilath TJ
    Arch Ophthalmol; 2002 Apr; 120(4):460-4. PubMed ID: 11934319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined chemotherapy and local treatment in the management of intraocular retinoblastoma.
    Brichard B; De Bruycker JJ; De Potter P; Neven B; Vermylen C; Cornu G
    Med Pediatr Oncol; 2002 Jun; 38(6):411-5. PubMed ID: 11984802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of new retinoblastomas after 6 cycles of chemoreduction for retinoblastoma in 162 eyes of 106 consecutive patients.
    Shields CL; Shelil A; Cater J; Meadows AT; Shields JA
    Arch Ophthalmol; 2003 Nov; 121(11):1571-6. PubMed ID: 14609913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The outcome of chemoreduction treatment in patients with Reese-Ellsworth group V retinoblastoma.
    Gündüz K; Shields CL; Shields JA; Meadows AT; Gross N; Cater J; Needle M
    Arch Ophthalmol; 1998 Dec; 116(12):1613-7. PubMed ID: 9869790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemoreduction for group E retinoblastoma: comparison of chemoreduction alone versus chemoreduction plus low-dose external radiotherapy in 76 eyes.
    Shields CL; Ramasubramanian A; Thangappan A; Hartzell K; Leahey A; Meadows AT; Shields JA
    Ophthalmology; 2009 Mar; 116(3):544-551.e1. PubMed ID: 19157557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy plus local treatment in the management of intraocular retinoblastoma.
    Murphree AL; Villablanca JG; Deegan WF; Sato JK; Malogolowkin M; Fisher A; Parker R; Reed E; Gomer CJ
    Arch Ophthalmol; 1996 Nov; 114(11):1348-56. PubMed ID: 8906025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histopathologic findings in eyes with retinoblastoma treated only with chemoreduction.
    Demirci H; Eagle RC; Shields CL; Shields JA
    Arch Ophthalmol; 2003 Aug; 121(8):1125-31. PubMed ID: 12912690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemoreduction for retinoblastoma: analysis of tumor control and risks for recurrence in 457 tumors.
    Shields CL; Mashayekhi A; Cater J; Shelil A; Meadows AT; Shields JA
    Trans Am Ophthalmol Soc; 2004; 102():35-44; discussion 44-5. PubMed ID: 15747743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macular retinoblastoma: evaluation of tumor control, local complications, and visual outcomes for eyes treated with chemotherapy and repetitive foveal laser ablation.
    Schefler AC; Cicciarelli N; Feuer W; Toledano S; Murray TG
    Ophthalmology; 2007 Jan; 114(1):162-9. PubMed ID: 17070578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined chemoreduction and adjuvant treatment for intraocular retinoblastoma.
    Shields CL; Shields JA; Needle M; de Potter P; Kheterpal S; Hamada A; Meadows AT
    Ophthalmology; 1997 Dec; 104(12):2101-11. PubMed ID: 9400771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conservative treatments of intraocular retinoblastoma.
    Lumbroso-Le Rouic L; Aerts I; Lévy-Gabriel C; Dendale R; Sastre X; Esteve M; Asselain B; Bours D; Doz F; Desjardins L
    Ophthalmology; 2008 Aug; 115(8):1405-10, 1410.e1-2. PubMed ID: 18222001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The International Classification of Retinoblastoma predicts chemoreduction success.
    Shields CL; Mashayekhi A; Au AK; Czyz C; Leahey A; Meadows AT; Shields JA
    Ophthalmology; 2006 Dec; 113(12):2276-80. PubMed ID: 16996605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term visual outcome following chemoreduction for retinoblastoma.
    Demirci H; Shields CL; Meadows AT; Shields JA
    Arch Ophthalmol; 2005 Nov; 123(11):1525-30. PubMed ID: 16286614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of intraocular retinoblastoma with vincristine and carboplatin.
    Rodriguez-Galindo C; Wilson MW; Haik BG; Merchant TE; Billups CA; Shah N; Cain A; Langston J; Lipson M; Kun LE; Pratt CB
    J Clin Oncol; 2003 May; 21(10):2019-25. PubMed ID: 12743157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemoreduction for retinoblastoma. Analysis of tumor control and risks for recurrence in 457 tumors.
    Shields CL; Mashayekhi A; Cater J; Shelil A; Meadows AT; Shields JA
    Am J Ophthalmol; 2004 Sep; 138(3):329-37. PubMed ID: 15364213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk Factors for Tumor Recurrence Following Primary Intravenous Chemotherapy (Chemoreduction) for Retinoblastoma in 869 Eyes of 551 Patients.
    Dalvin LA; Bas Z; Tadepalli S; Rao R; Vaidya S; Pacheco R; Shields CL
    J Pediatr Ophthalmol Strabismus; 2020 Jul; 57(4):224-234. PubMed ID: 32687206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.